Ixico confident as full-year revenue, earnings decline
6th Aug 2021 14:53
(Sharecast News) - Data analytics company Ixico updated the market on its trading on Friday, confirming that despite a "challenging" business environment, it expected to deliver £8.7m in revenues for the 2021 financial year.
Read moreIxico H1 revenues grow despite Covid-19 impacts on clinical development sector
26th Apr 2021 09:06
(Sharecast News) - Clinical research firm Ixico said on Monday that revenues were expected to have improved in the six months ended 31 March, despite the impacts of the Covid-19 pandemic on the clinical development sector.
Read moreIxico strikes collaboration deal with Microsoft
15th Mar 2021 10:13
(Sharecast News) - Data analytics company Ixico said on Monday that it had struck a collaboration agreement with tech giant Microsoft to develop its artificial intelligence analytics platform for the global pharmaceutical industry.
Read moreIxico selected for Alzheimer's clinical trial
10th Mar 2021 14:30
(Sharecast News) - Neuroscience artificial intelligence (AI) analytics company Ixico has been selected by a current mid-sized biopharmaceutical client to support a phase 2 Alzheimer's disease clinical trial, it announced on Wednesday.
Read moreIxico awarded ?3.4m contract by existing client
24th Dec 2020 12:20
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been awarded a £3.4m contract to run over 4.5 years by an existing client, it announced on Thursday, for a spinocerebellar ataxia type-3 (SCA3) trial.
Read moreIxico to provide neuroimaging solutions to unnamed global pharmaceutical group
8th Dec 2020 09:26
(Sharecast News) - Data analytics firm Ixico has secured a contract for neuroimaging solutions with a "large global pharmaceutical company".
Read moreIxico executes contract for Huntington's disease clinical trial
27th Nov 2020 12:09
(Sharecast News) - Neuroscience data analytics company Ixico has executed a contract to provide neuroimaging services that would support a phase 1b and 2 clinical trial for Huntington's disease, it announced on Friday.
Read moreIxico wins new contracts in Alzheimer's clinical trials
3rd Nov 2020 10:43
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Alzheimer's disease (AD) clinical trials, it announced on Tuesday.
Read moreIxico secures two Huntington's disease clinical trial contracts
22nd Oct 2020 15:00
(Sharecast News) - Neuroscience data analytics company Ixico has secured new contracts in Huntington's disease clinical trials.
Read moreIxico FY revenues grow by more than a quarter
19th Oct 2020 09:38
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.
Read moreIxico enters deal with NUY Langone Health for drug trial
16th Oct 2020 16:23
(Sharecast News) - Data analytics company Ixico has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus, approved by the FDA to prevent organ transplant rejection and for the treatment of a rare and progressive lung disease called lymphangioleiomyomatosis, is also able to slow the progression of disease in people with multiple system atrophy (MSA).
Read moreIxico joins Friedreich's Ataxia research consortium
24th Sep 2020 16:30
(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).
Read moreIxico joins Friedreich's Ataxia research consortium
24th Sep 2020 16:30
(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).
Read moreIxico selected to support Alzheimer's trial
21st Sep 2020 13:35
(Sharecast News) - Data analytics company Ixico has been selected by the Global Alzheimer's Platform Foundation (GAP) to support its planned 'Bio-Hermes' trial.
Read moreIxico FY revenues, underlying earnings ahead of forecasts
24th Aug 2020 09:18
(Sharecast News) - Data analytics company Ixico said on Monday that it had recorded "stronger-than-anticipated" second-half revenues and underlying earnings despite Covid-19.
Read more